Massive study investigates if popular heart drugs favor one sex
NCT ID NCT07188545
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 27 times
Summary
This study looks at millions of medical records to see if two common drug types (GLP-1 agonists and SGLT2 inhibitors) affect heart and kidney health differently in men versus women. Researchers will compare people taking these drugs to those on other medications. The goal is to find any sex-based differences in how well these drugs work, which could lead to more personalized treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR-KIDNEY-METABOLIC SYNDROME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Ohio State University
Columbus, Ohio, 43202, United States
Conditions
Explore the condition pages connected to this study.